trial · primary record
Placebo IV
Non-Segmental Vitiligo (NSV)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2027-12 |
| Primary endpoint | Mean percent change from baseline in F-VASI at Week 28 |
| Registry ID | NCT07889492 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:14.958Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07889492
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.